Evidence map›Paper›PMID 41922584›Full record

ArticleAMB Express2026

Enhanced secretion of an Agrocybe aegerita peroxygenase variant in K. phaffii using the native signal peptide.

Ginevra Camboni, Rebecca Preece, Katy A S Cornish, Jared Cartwright, Gideon Grogan

Abstract read
In one paragraph

Article in AMB Express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ginevra CamboniDepartments of Chemistry, University of York, Heslington, YO10 5DD, York, United Kingdom.
Rebecca PreeceDepartments of Biology, University of York, Heslington, York, YO10 5DD, United Kingdom.
Katy A S CornishDepartments of Chemistry, University of York, Heslington, YO10 5DD, York, United Kingdom.
Jared CartwrightDepartments of Biology, University of York, Heslington, York, YO10 5DD, United Kingdom. jared.cartwright@york.ac.uk.
Gideon GroganDepartments of Chemistry, University of York, Heslington, YO10 5DD, York, United Kingdom. gideon.grogan@york.ac.uk.

Funding

Engineering and Physical Sciences Research Council EP/X014886/1UK EPSRC EP/X014886/1
6 · The paper itself

Abstract

Unspecific Peroxygenases (UPOs) are enzymes with significant potential as catalysts in synthetic chemistry as they catalyse selective oxygenation reactions on organic substrates at the expense of only hydrogen peroxide as the external oxidant. The demand for UPOs has stimulated considerable research into efficient heterologous expression systems for their production, which have included optimisation of the signal peptide (SP) included upstream of the UPO gene. In this study we report a comparison of the production of the prototypical and widely-used UPO variant from the fungus Agrocybe aegerita (rAaeUPO-PaDa-I-H) using both its native SP and variant SPs evolved for improved heterologous expression in yeast hosts. The results show that improvements in protein production identified using variant SPs in S. cerevisiae are not necessarily extended to the yeast Komagataella phaffii. Indeed in K. phaffii we observed a five to sevenfold improvement in the activity of crude secretates produced using the native fungal SP of AaeUPO, compared with SPs that were evolved for improved expression and screened in S. cerevisiae These findings suggest that superior yields of this widely-used UPO can be obtained from scaled production in K. phaffii by using the native SP from the source fungus.

Indexed as

Komagataella phaffiiPichia pastorisSaccharomyces cerevisiaeSignal peptideUnspecific peroxygenase

Identifiers

PMID41922584
PMCPMC13168419

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.